Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic
  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Energy Focus, Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results

Conference Call to be Held Today at 11 am ET

Energy Focus, Inc. (NASDAQ:EFOI), a leader in sustainable, energy-efficient lighting and controls systems and ultraviolet-c light disinfection (“UVCD”) products for the commercial, military maritime and consumer markets, today announced financial results for its fourth quarter and fiscal year ended December 31, 2021.

Full-Year 2021 and Subsequent Business Highlights

  • Net sales of $9.9 million, down 41.4% from 2020, reflecting continued fluctuations in timing of military orders and government funding availability, ongoing COVID-19 related business challenges for its customers, and supply chain and logistics delays.
  • Gross profit margin of 17.2%, down from 30.8% in 2020, primarily due to lower sales and the overhang of fixed costs against lower sales volume.
  • Loss from operations of $8.7 million, compared to a loss from operations in 2020 of $4.1 million.
  • Net loss of $7.9 million, or ($1.73) per basic and diluted share of common stock, compared to a net loss of $6.0 million, or ($1.83) per basic and diluted share of common stock, in 2020.
  • Cash of $2.7 million as of December 31, 2021, included in total availability (as defined under “Non-GAAP Measures” below) of $4.4 million, as compared to cash of $1.8 million and total availability of $3.5 million as of December 31, 2020.
  • Net proceeds of approximately $4.0 million from December 2021 private placement of common stock and warrants to certain institutional investors.
  • nUVo™ Traveler production units shipping as of the end of the fourth quarter of 2021; nUVo™ Tower began shipping in January 2022.
  • Appointed the Lead Independent Director, an experienced venture capitalist, as Interim CEO while search is underway.
  • Added seasoned lighting and consumer product executives to Board of Directors.

“Over the past year, amidst significant upheaval to our primary commercial and military customers and markets and our efforts to bring safely enclosed, high-dose UVCD products to market, we have built an organization ready to execute,” commented Stephen Socolof, Interim CEO and Lead Independent Director. “Our focus for 2022 is on that execution, both in our traditional markets, centered around our innovative and differentiated EnFocus™ powerline and control platform, our Redcap® emergency battery backup tubular LEDs, our ruggedized LED solutions for military and maritime applications, and our new UVCD solutions designed to destroy over 99.9 percent of various airborne pathogens, including coronavirus, influenza and mold. Importantly, we are increasing our initiatives on our core markets, light commercial and particularly military applications, where Energy Focus has a very recognized brand and built competitive advantages centered around differentiated technology and intellectual property. Our focus is to re-engage these markets to drive improved results, complemented by the contribution from our UVCD products that could broaden our market reach and scalability.”

On January 11, 2022, the Board of Directors of Energy Focus, Inc. (the “Company”) appointed Mr. Socolof, the Company’s Lead Independent Director, to serve as Interim Chief Executive Officer, replacing James Tu, the former Chief Executive Officer. Mr. Socolof has served as a member of the Board of Directors since May 2019, and as the Company’s Lead Independent Director since September 2019. He has been Managing Partner of Tech Council Ventures, an early-stage venture capital firm, since 2018 and remains a Managing Partner of New Venture Partners, a venture capital firm that he co-founded in 2001. On February 11, 2022, the Company entered into a Separation and Release Agreement with Mr. Tu and he resigned from the Board of Directors. The Board of Directors has begun a search for a permanent Chief Executive Officer.

In addition, on February 24, 2022, the Company announced that its Board of Directors had appointed Jeffery R. Parker and Brian J. Lagarto as independent directors of the Company. Mr. Parker, 58, has spent nearly 30 years managing companies in the display, LED, medical and lighting markets. He has a proven track record of driving growth and market leadership in the lighting industry by bringing innovative products to market, and since 2019, has served as the Chief Executive Officer of Luminii, LLC, a manufacturer of architectural LED lighting systems. Mr. Lagarto, 56, retired in 2021 from SharkNinja Operating LLC, a leading global producer of small household appliances under the Shark and Ninja brands. At SharkNinja, Mr. Lagarto served primarily as Executive Vice President, Chief Financial Officer from 2009 to 2017, as well as Chief Operating Officer from 2017 to 2018, with responsibility for global finance and operations. From 2019 until his retirement, he served as Chief People & Strategy Officer, with responsibility for corporate strategy, organizational design, talent and culture.

“As we move forward, we continue to focus on improving our gross and operating margins through innovation, as well as value add and value engineering work at the cost of goods sold level, and management rigor at the sales and operating levels,” continued Mr. Socolof. “Our development work on the initial UVCD solutions is complete, and we have concentrated our near-term focus on applications with immediate potential, and on opportunities of which resources can be quickly adjusted based on market reaction. In addition, we have reorganized our operations to better focus on the two core areas of our business, LED lighting and control solutions and our new UVC disinfection solutions. In 2021, Greg Galluccio joined us as Senior Vice President of Product Management and Engineering. Greg has 35 years of diverse experience in the electrical and lighting industries at much larger organizations, such as Underwriters Laboratories (UL) and Leviton Manufacturing, and he is charged with refreshing and defining our technology roadmap and go-to-market strategy. I am also excited about the recent additions of Jeff Parker and Brian Lagarto to our board of directors. Jeff’s lighting industry expertise, and Brian’s extensive experience scaling up a worldwide consumer products brand, will be valuable resources for Energy Focus.”

Full-Year 2021 Financial Results

Net sales were $9.9 million for 2021, compared with $16.8 million for 2020. Net sales from commercial products were $4.7 million, or 47.5% of total net sales, for 2021, compared with $5.4 million, or 32.1% of total net sales, for 2020. The decrease in net sales of commercial products reflects continuing fluctuations in the timing, pace and size of commercial projects, including impacts of the COVID-19 pandemic. Net sales from military and maritime market (“MMM”) products were $5.2 million, or 52.5% of total net sales, for 2021, compared with $11.4 million, or 67.9% of total net sales, for 2020. The decrease in net MMM product sales in 2021, as compared to 2020 was mainly due to the reduced availability of government funding and the delayed timing of expected orders, as well as higher in-house sales and short-term contracts awarded and performed in 2020.

Gross profit was $1.7 million, or 17.2% of net sales, for 2021, compared with gross profit of $5.2 million, or 30.8% of net sales, for 2020. The year-over-year decrease in gross margin was driven primarily by lower sales, resulting in an overhang in fixed costs against the lower sales volume of $1.0 million, or 10.1% of net sales, and unfavorable inventory and warranty reserve adjustments aggregating $0.3 million, or 2.9% of net sales. Gross margin for 2021 included favorable price and usage variances for material and labor of $0.8 million, or 8.3% of net sales. Adjusted gross margin, as defined under “Non-GAAP Measures” below, was 18.8% for full-year 2021, compared to 27.1% in the prior year, primarily driven by low sales in 2021.

Operating loss was $8.7 million for 2021. This compares with an operating loss of $4.1 million for 2020. Net loss was $7.9 million, or ($1.73) per basic and diluted share of common stock, for 2021, inclusive of a non-cash, pre-tax gain of $0.8 million from the forgiveness of the Company’s Paycheck Protection Program loan, as well as other income recorded relating to the Employee Retention Tax Credit (“ERTC”) of $0.9 million ($431 thousand of which was received during the fourth quarter of 2021, with the remainder expected during 2022). This compares with a net loss of $6.0 million, or ($1.83) per basic and diluted share of common stock, for 2020, which included a non-cash, pre-tax loss of $1.1 million resulting from the revaluation of the warrant liability through December 2020, when the outstanding warrantholders agreed to modifications that qualified the warrants for equity accounting treatment.

Adjusted EBITDA, as defined under “Non-GAAP Measures” below, was a loss of $7.9 million for 2021, compared with a loss of $3.5 million for 2020. The increased Adjusted EBITDA loss in 2021, as compared to 2020, was primarily due to lower sales and the overhang of fixed costs over the lower sales volume.

Cash was $2.7 million as of December 31, 2021 as compared to $1.8 million as of December 31, 2020. As of December 31, 2021, the Company had total availability, as defined under “Non-GAAP Measures” below, of $4.4 million, which consisted of $2.7 million of cash and $1.7 million of additional borrowing availability under its credit facilities. This compares to total availability of $3.5 million as of December 31, 2020.

Fourth Quarter 2021 Financial Results:

Net sales were $2.4 million for the fourth quarter of 2021, down 35.8% compared with $3.7 million in the fourth quarter of 2020. Net sales from commercial products were $1.2 million, or 48.6% of total net sales, for the fourth quarter of 2021, flat as compared to the fourth quarter of 2020, reflecting the continuing impacts on our customers of the COVID-19 pandemic due to fluctuations in the timing, pace, and size of commercial projects. Net sales from MMM products were $1.2 million, or 51.4% of total net sales, for the fourth quarter of 2021, down from $2.6 million, or 69.2% of total net sales, in the fourth quarter of 2020. Sales were higher in the prior period due to a large order from a U.S. shipbuilder in 2020 that drove a significant part of the MMM business. Sequentially, net sales were down slightly as compared to $2.7 million in the third quarter of 2021, mainly due to a 23.2% decrease in commercial product sales from the third quarter of 2021.

Gross profit was $0.2 million, or 7.9% of net sales, for the fourth quarter of 2021, compared with gross profit of $1.4 million, or 38.3% of net sales, in the fourth quarter of 2020. Sequentially, this compares with a gross profit of $0.6 million, or 20.5% of net sales, in the third quarter of 2021. The year-over-year decline in gross margin was primarily driven by lower MMM product sales, an overhang of fixed costs of $0.5 million, or 19.1% of net sales, against the lower sales volume, a negative margin impact from sales product mix of $0.2 million, or 8.7% of net sales, and unfavorable inventory reserve adjustments of $0.2 million, or 9.5% of net sales. These were offset slightly by favorable price and usage variances for material and labor of $0.2 million, or 7.4% of net sales, in the fourth quarter of 2021.

Adjusted gross margin, as defined under “Non-GAAP Measures” below, was 14.7% for the fourth quarter of 2021, compared to 27.7% in the fourth quarter of 2020 and compared sequentially to 17.9% in the third quarter of 2021. The decrease in adjusted gross margin from the fourth quarter of 2020 is mainly due to lower MMM sales and negative margin impacts from increased fixed costs and product mix as discussed above. The decrease in adjusted gross margin from the third quarter of 2021 is primarily attributable to lower commercial product sales and an overhang of fixed costs of $0.2 million, or 9.9% of net sales, against the lower sales volume.

Operating loss was $2.4 million for the fourth quarter of 2021, compared with an operating loss of $0.9 million in the fourth quarter of 2020. Sequentially, this compares to an operating loss of $1.8 million in the third quarter of 2021. The year-over-year increase in the operating loss was primarily attributable to lower net sales, an increase in the SG&A impact of increased headcount and salaries, and increased advertising and promotion costs.

Net loss was $2.6 million in the fourth quarter of 2021, compared with net income of $0.1 million in the fourth quarter of 2020, which was inclusive of a $1.2 million non-cash, pre-tax gain resulting from the final revaluation of the warrant liability during the fourth quarter of 2020. Sequentially, this compares to a net loss of $1.1 million in the third quarter of 2021, which was inclusive of a $0.9 million non-cash, pre-tax gain resulting from other income recorded relating to the ERTC.

Net loss per basic and diluted share of common stock was ($0.50) for the fourth quarter of 2021, compared with net income per basic and diluted share of common stock of $0.01 in the fourth quarter of 2020. Sequentially, this compares to a net loss per basic and diluted share of common stock of ($0.22) in the third quarter of 2021.

Adjusted EBITDA, as defined under “Non-GAAP Measures” below, was a loss of $2.2 million for the fourth quarter of 2021, compared with a loss of $0.8 million in the fourth quarter of 2020 and a loss of $1.7 million in the third quarter of 2021.

Conference Call:

The Company will host a conference call and webcast today, March 17, 2022 at 11 a.m. ET to review the fourth quarter and full-year 2021 results, followed by a Q&A session. To participate in the call, please dial toll-free 1-877-451-6152 or international 1-201-389-0879, and reference conference ID 13726068.

The conference call will be simultaneously webcast. To listen to the webcast, log on to it at: https://viavid.webcasts.com/starthere.jsp?ei=1522523&tp_key=55cae2bf30. The webcast will be available at this link through April 1, 2022. Financial information presented on the call, including the earnings press release, will be available on the investors section of Energy Focus’ website at investors.energyfocus.com.

About Energy Focus

Energy Focus is an industry-leading innovator of sustainable light-emitting diode (“LED”) lighting and lighting control technologies and solutions, as well as UV-C Disinfection technologies and solutions. As the creator of the first flicker-free LED lamps, Energy Focus develops high quality LED lighting products and controls that provide extensive energy and maintenance savings, as well as aesthetics, safety, health and sustainability benefits over conventional lighting. Our EnFocus™ lighting control platform enables existing and new buildings to provide quality, convenient and affordable, dimmable and color-tunable, circadian and human-centric lighting capabilities. In addition, our patent-pending UVCD technologies and products aim to provide effective, reliable and affordable UVCD solutions for buildings, facilities and homes. Energy Focus’ customers include U.S. and U.S. ally navies, U.S. federal, state and local governments, healthcare and educational institutions, as well as Fortune 500 companies. Since 2007, Energy Focus has installed approximately 900,000 lighting products across the U.S. Navy fleet, including tubular LEDs, waterline security lights, explosion-proof globes and berth lights, saving more than five million gallons of fuel and 300,000 man-hours in lighting maintenance annually. Energy Focus is headquartered in Solon, Ohio. For more information, visit our website at www.energyfocus.com.

Forward Looking Statements:

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements can generally be identified by the use of forward-looking terminology, including the terms “believes,” “estimates,” “anticipates,” “expects,” “feels,” “seeks,” “forecasts,” “projects,” “intends,” “plans,” “may,” “will,” “should,” “could” or “would” or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include all matters that are not historical facts and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies, capital expenditures, and the industry in which we operate. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Although we base these forward-looking statements on assumptions that we believe are reasonable when made in light of the information currently available to us, we caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and industry developments may differ materially from statements made in or suggested by the forward-looking statements contained in this release. We believe that important factors that could cause our actual results to differ materially from forward-looking statements include, but are not limited to: (i) instability in the U.S. and global economies and business interruptions experienced by us, our customers and our suppliers as a result of the COVID-19 pandemic and related impacts on travel, trade and business operations; (ii) the competitiveness and market acceptance of our LED lighting, control and UVCD technologies, services and products; (iii) our ability to compete effectively against companies with lower prices or cost structures, greater resources, or more rapid development capabilities, and new competitors in our target markets; (iv) our ability to extend our product portfolio into consumer products; (v) our ability to realize the expected novelty, disinfection effectiveness, affordability and estimated delivery timing of our UVCD products and their appeal compared to other products; (vi) our ability to increase demand in our targeted markets and to manage sales cycles that are difficult to predict and may span several quarters; (vii) the timing of large customer orders, significant expenses and fluctuations between demand and capacity as we invest in growth opportunities; (viii) our ability to successfully scale our network of sales representatives, agents, distributors and other channel partners to compete with the sales reach of larger, established competitors; (ix) our ability to implement plans to increase sales and control expenses; (x) our reliance on a limited number of customers for a significant portion of our revenue, and our ability to maintain or grow such sales levels; (xi) our ability to add new customers to reduce customer concentration; (xii) our need for additional financing in the near term to continue our operations; (xiii) our ability to refinance or extend maturing debt on acceptable terms or at all; (xiv) our ability to continue as a going concern for a reasonable period of time; (xv) our ability to attract and retain a new chief executive officer (“Chief Executive Officer”); (xvi) our ability to attract, develop and retain qualified personnel, and to do so in a timely manner; (xvii) our reliance on a limited number of third-party suppliers and research and development partners, our ability to manage third-party product development and obtain critical components and finished products from such suppliers on acceptable terms and of acceptable quality despite ongoing global supply chain challenges, and the impact of our fluctuating demand on the stability of such suppliers; (xviii) our ability to timely, efficiently and cost-effectively transport products from our third-party suppliers to our facility by ocean marine and other logistics channels despite global supply chain and logistics disruptions; (xix) the impact of any type of legal inquiry, claim or dispute; (xx) the inflationary or deflationary general economic conditions in the United States and in other markets in which we operate or secure products, which could affect our ability to obtain raw materials, component parts, freight, energy, labor, and sourced finished goods in a timely and cost-effective manner; (xxi) our dependence on military maritime customers and on the levels and timing of government funding available to such customers, as well as the funding resources of our other customers in the public sector and commercial markets; (xxii) business interruptions resulting from geopolitical actions, including war and terrorism, natural disasters, including earthquakes, typhoons, floods and fires, or from health epidemics, or pandemics or other contagious outbreaks; (xxiii) our ability to respond to new lighting and air disinfection technologies and market trends; (xxiv) our ability to fulfill our warranty obligations with safe and reliable products; (xxv) any delays we may encounter in making new products available or fulfilling customer specifications; (xxvi) any flaws or defects in our products or in the manner in which they are used or installed; (xxvii) our ability to protect our intellectual property rights and other confidential information, and manage infringement claims made by others; (xxviii) our compliance with government contracting laws and regulations, through both direct and indirect sale channels, as well as other laws, such as those relating to the environment and health and safety; (xxix) risks inherent in international markets, such as economic and political uncertainty, changing regulatory and tax requirements and currency fluctuations, including tariffs and other potential barriers to international trade; (xxx) our ability to maintain effective internal controls and otherwise comply with our obligations as a public company; and (xxxi) our ability to maintain compliance with the continued listing standards of The Nasdaq Stock Market. For additional factors that could cause our actual results to differ materially from the forward-looking statements, please refer to our most recent annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission.

Condensed Consolidated Balance Sheets

(Audited)

(in thousands)

 

 

December 31,

 

2021

 

2020

ASSETS

 

 

 

Current assets:

 

 

 

Cash

$

2,682

 

$

1,836

Trade accounts receivable, less allowances of $14 and $8, respectively

 

1,240

 

 

2,021

Inventories, net

 

7,866

 

 

5,641

Short-term deposits

 

712

 

 

796

Prepaid and other current assets

 

924

 

 

782

Total current assets

 

13,424

 

 

11,076

 

 

 

 

Property and equipment, net

 

675

 

 

420

Operating lease, right-of-use asset

 

292

 

 

794

Restructured lease, right-of-use asset

 

 

 

107

Total assets

$

14,391

 

$

12,397

 

 

 

 

LIABILITIES

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

2,235

 

$

2,477

Accrued liabilities

 

265

 

 

45

Accrued legal and professional fees

 

104

 

 

149

Accrued payroll and related benefits

 

718

 

 

885

Accrued sales commissions

 

57

 

 

95

Accrued restructuring

 

 

 

11

Accrued warranty reserve

 

295

 

 

227

Deferred revenue

 

268

 

 

72

Operating lease liabilities

 

325

 

 

598

Restructured lease liabilities

 

 

 

168

Finance lease liabilities

 

1

 

 

3

Streeterville note, net of discount and loan origination fees

 

1,719

 

 

PPP loan

 

 

 

529

Credit line borrowings, net of loan origination fees

 

2,169

 

 

2,298

Total current liabilities

 

8,156

 

 

7,557

Condensed Consolidated Balance Sheets

(Audited)

(in thousands)

 

 

December 31,

 

2021

 

2020

Operating lease liabilities, net of current portion

 

26

 

 

 

318

 

Finance lease liabilities, net of current portion

 

 

 

 

1

 

PPP loan, net of current maturities

 

 

 

 

266

 

Total liabilities

 

8,182

 

 

 

8,142

 

 

 

 

 

STOCKHOLDERS' EQUITY

 

 

 

Preferred stock, par value $0.0001 per share:

 

 

 

Authorized: 5,000,000 shares (3,300,000 shares designated as Series A Convertible Preferred Stock) at December 31, 2021 and December 31, 2020)

 

 

 

Issued and outstanding: 876,447 shares at December 31, 2021 and 2,597,470 shares at December 31, 2020

 

 

 

 

 

Common stock, par value $0.0001 per share:

 

 

 

Authorized: 50,000,000 shares at December 31, 2021 and December 31, 2020

 

 

 

Issued and outstanding: 6,368,549 shares at December 31, 2021 and 3,525,374 shares at December 31, 2020

 

 

 

 

 

Additional paid-in capital

 

144,953

 

 

 

135,113

 

Accumulated other comprehensive loss

 

(3

)

 

 

(3

)

Accumulated deficit

 

(138,741

)

 

 

(130,855

)

Total stockholders' equity

 

6,209

 

 

 

4,255

 

Total liabilities and stockholders' equity

$

14,391

 

 

$

12,397

 

Condensed Consolidated Statements of Operations

(In thousands, except per share data)

 

 

Three months ended

 

Twelve months ended

 

December 31,

 

September 30,

 

December 31,

 

December 31,

 

2021

 

2021

 

2020

 

2021

 

2020

Net sales

$

2,405

 

 

$

2,749

 

 

$

3,746

 

 

$

9,865

 

 

$

16,828

 

Cost of sales

 

2,216

 

 

 

2,186

 

 

 

2,312

 

 

 

8,167

 

 

 

11,643

 

Gross profit

 

189

 

 

 

563

 

 

 

1,434

 

 

 

1,698

 

 

 

5,185

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Product development

 

464

 

 

 

404

 

 

 

419

 

 

 

1,891

 

 

 

1,415

 

Selling, general, and administrative

 

2,081

 

 

 

1,968

 

 

 

1,897

 

 

 

8,535

 

 

 

7,900

 

Restructuring (credits) expense

 

 

 

 

1

 

 

 

(16

)

 

 

(21

)

 

 

(60

)

Total operating expenses

 

2,545

 

 

 

2,373

 

 

 

2,300

 

 

 

10,405

 

 

 

9,255

 

Loss from operations

 

(2,356

)

 

 

(1,810

)

 

 

(866

)

 

 

(8,707

)

 

 

(4,070

)

 

 

 

 

 

 

 

 

 

 

Other expenses:

 

 

 

 

 

 

 

 

 

Interest expense

 

272

 

 

 

177

 

 

 

137

 

 

 

792

 

 

 

481

 

Gain on forgiveness of PPP loan

 

 

 

 

 

 

 

 

 

 

(801

)

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

117

 

 

 

 

 

 

276

 

Other income - employee retention tax credit

 

(14

)

 

 

(862

)

 

 

 

 

 

(876

)

 

 

 

(Gain) loss from change in fair value of warrants

 

 

 

 

 

 

 

(1,188

)

 

 

 

 

 

1,086

 

Other expenses

 

18

 

 

 

15

 

 

 

6

 

 

 

65

 

 

 

73

 

 

 

 

 

 

 

 

 

 

 

(Loss) income from operations before income taxes

 

(2,632

)

 

 

(1,140

)

 

 

62

 

 

 

(7,887

)

 

 

(5,986

)

Benefit from income taxes

 

(1

)

 

 

 

 

 

(3

)

 

 

(1

)

 

 

(5

)

Net (loss) income

$

(2,631

)

 

$

(1,140

)

 

$

65

 

 

$

(7,886

)

 

$

(5,981

)

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share attributable to common stockholders - basic1:

 

 

 

 

 

 

 

 

 

From operations

$

(0.50

)

 

$

(0.22

)

 

$

0.01

 

 

$

(1.73

)

 

$

(1.83

)

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share attributable to common stockholders - diluted1:

 

 

 

 

 

 

 

 

 

From operations

$

(0.50

)

 

$

(0.22

)

 

$

0.01

 

 

$

(1.73

)

 

$

(1.83

)

 

 

 

 

 

 

 

 

 

 

Weighted average shares used in computing net (loss) income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

5,312

 

 

 

5,086

 

 

 

3,491

 

 

 

4,561

 

 

 

3,270

 

Diluted

 

5,312

 

 

 

5,086

 

 

 

4,307

 

 

 

4,561

 

 

 

3,270

 

 

 

 

 

 

 

 

 

 

 

1 In accordance with Topic 260 "Earnings Per Share", net income has been allocated to holders of common shares and participating securities including preferred shares and warrants, accordingly. Earnings per share disclosed above utilizes income attributable to common shareholders after this required allocation.

The following table summarizes the computation of basic and diluted earnings per share:

(In thousands, except per share data)

 

Three months ended

 

Twelve months ended

 

December 31,

 

September 30,

 

December 31,

 

December 31,

 

2021

 

2021

 

2020

 

2021

 

2020

Net (loss) income

$

(2,631

)

 

$

(1,140

)

 

$

65

 

$

(7,886

)

 

$

(5,981

)

Less: Undistributed earnings allocated to participating securities

 

 

 

 

 

 

 

18

 

 

 

 

 

 

Net (loss) income available to common stockholders

$

(2,631

)

 

$

(1,140

)

 

$

47

 

$

(7,886

)

 

$

(5,981

)

 

 

 

 

 

 

 

 

 

 

Weighted average shares used in computing net (loss) income per common share:

 

 

 

 

 

 

 

 

 

Basic

 

5,312

 

 

 

5,086

 

 

 

3,491

 

 

4,561

 

 

 

3,270

 

Options

 

 

 

 

 

 

 

102

 

 

 

 

 

 

Warrants

 

 

 

 

 

 

 

194

 

 

 

 

 

 

Restricted stock units

 

 

 

 

 

 

 

1

 

 

 

 

 

 

Convertible preferred stock

 

 

 

 

 

 

 

519

 

 

 

 

 

 

Diluted

 

5,312

 

 

 

5,086

 

 

 

4,307

 

 

4,561

 

 

 

3,270

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share attributable to common stockholders - basic:

 

 

 

 

 

 

 

 

 

From operations

$

(0.50

)

 

$

(0.22

)

 

$

0.01

 

$

(1.73

)

 

$

(1.83

)

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share attributable to common stockholders - diluted:

 

 

 

 

 

 

 

 

 

From operations

$

(0.50

)

 

$

(0.22

)

 

$

0.01

 

$

(1.73

)

 

$

(1.83

)

Condensed Consolidated Statements of Cash Flows

(In thousands)

 

 

Three months ended

 

Twelve months ended

 

December 31,

 

September 30,

 

December 31,

 

December 31,

 

2021

 

2021

 

2020

 

2021

 

2020

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net (loss) income

$

(2,631

)

 

$

(1,140

)

 

$

65

 

 

$

(7,886

)

 

$

(5,981

)

Adjustments to reconcile net (loss) income to net cash used in operating activities:

 

 

 

 

 

 

 

 

 

Other income - employee retention tax credit

 

(14

)

 

 

(862

)

 

 

 

 

 

(876

)

 

 

 

Gain on forgiveness of PPP loan

 

 

 

 

 

 

 

 

 

 

(801

)

 

 

 

Depreciation

 

45

 

 

 

43

 

 

 

44

 

 

 

188

 

 

 

184

 

Stock-based compensation

 

42

 

 

 

39

 

 

 

35

 

 

 

429

 

 

 

131

 

Change in fair value of warrants

 

 

 

 

 

 

 

(1,188

)

 

 

 

 

 

1,086

 

Provision for doubtful accounts receivable

 

(4

)

 

 

2

 

 

 

1

 

 

 

6

 

 

 

(20

)

Provision for slow-moving and obsolete inventories and valuation reserves

 

165

 

 

 

(70

)

 

 

(381

)

 

 

156

 

 

 

(610

)

Provision for warranties

 

55

 

 

 

1

 

 

 

(3

)

 

 

68

 

 

 

31

 

Amortization of loan discounts and origination fees

 

72

 

 

 

61

 

 

 

174

 

 

 

230

 

 

 

395

 

Loss on dispositions of property and equipment

 

 

 

 

 

 

 

8

 

 

 

 

 

 

8

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

 

Accounts receivable

 

393

 

 

 

(500

)

 

 

1,447

 

 

 

783

 

 

 

377

 

Inventories

 

(276

)

 

 

444

 

 

 

(1

)

 

 

(2,381

)

 

 

1,137

 

Short-term deposits

 

170

 

 

 

(62

)

 

 

(258

)

 

 

257

 

 

 

(670

)

Prepaid and other assets

 

788

 

 

 

(91

)

 

 

41

 

 

 

669

 

 

 

(18

)

Accounts payable

 

(341

)

 

 

(164

)

 

 

(715

)

 

 

(423

)

 

 

1,096

 

Accrued and other liabilities

 

(75

)

 

 

53

 

 

 

(104

)

 

 

(380

)

 

 

349

 

Deferred revenue

 

266

 

 

 

(69

)

 

 

(33

)

 

 

196

 

 

 

54

 

Total adjustments

 

1,286

 

 

 

(1,175

)

 

 

(933

)

 

 

(1,879

)

 

 

3,530

 

Net cash used in operating activities

 

(1,345

)

 

 

(2,315

)

 

 

(868

)

 

 

(9,765

)

 

 

(2,451

)

 

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Acquisitions of property and equipment

 

(132

)

 

 

(100

)

 

 

(52

)

 

 

(443

)

 

 

(223

)

Net cash used in investing activities

 

(132

)

 

 

(100

)

 

 

(52

)

 

 

(443

)

 

 

(223

)

Condensed Consolidated Statements of Cash Flows

(In thousands)

 

 

Three months ended

 

Twelve months ended

 

December 31,

 

September 30,

 

December 31,

 

December 31,

 

2021

 

2021

 

2020

 

2021

 

2020

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Proceeds from the issuance of common stock and warrants

 

4,500

 

 

 

 

 

 

 

 

 

9,500

 

 

 

2,749

 

Proceeds from warrants exercised

 

274

 

 

 

 

 

 

242

 

 

 

801

 

 

 

918

 

Offering costs paid on the issuance of common stock and warrants

 

(499

)

 

 

(1

)

 

 

(36

)

 

 

(969

)

 

 

(510

)

Proceeds from PPP loan

 

 

 

 

 

 

 

 

 

 

 

 

 

795

 

Proceeds from exercises of stock options and employee stock purchase plan purchases

 

21

 

 

 

 

 

 

70

 

 

 

80

 

 

 

100

 

Principal payments under finance lease obligations

 

 

 

 

(1

)

 

 

 

 

 

(3

)

 

 

(3

)

Common stock withheld in lieu of income tax withholding on vesting of restricted stock units

 

 

 

 

1

 

 

 

 

 

 

(1

)

 

 

(3

)

Payments for deferred financing & termination costs

 

 

 

 

 

 

 

 

 

 

(30

)

 

 

(320

)

Payments on the Iliad Note

 

 

 

 

 

 

 

(330

)

 

 

 

 

 

(1,306

)

Proceeds from the Streeterville Note

 

 

 

 

 

 

 

 

 

 

1,515

 

 

 

 

Net payments on credit line borrowings - Austin Facility

 

 

 

 

 

 

 

 

 

 

 

 

 

(719

)

Net (payments on) proceeds from credit line borrowings - Credit Facilities

 

(518

)

 

 

1,128

 

 

 

236

 

 

 

(181

)

 

 

2,459

 

Net cash provided by financing activities

 

3,778

 

 

 

1,127

 

 

 

182

 

 

 

10,712

 

 

 

4,160

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and restricted cash

 

2,301

 

 

 

(1,288

)

 

 

(738

)

 

 

504

 

 

 

1,486

 

Cash and restricted cash at beginning of period

 

381

 

 

 

1,669

 

 

 

2,916

 

 

 

2,178

 

 

 

692

 

Cash and restricted cash at end of period

$

2,682

 

 

$

381

 

 

$

2,178

 

 

$

2,682

 

 

$

2,178

 

 

 

 

 

 

 

 

 

 

 

Classification of cash and restricted cash:

 

 

 

 

 

 

 

 

 

Cash

$

2,682

 

 

$

381

 

 

$

1,836

 

 

$

2,682

 

 

$

1,836

 

Restricted cash held in other assets

 

 

 

 

 

 

 

342

 

 

 

 

 

 

342

 

Cash and restricted cash

$

2,682

 

 

$

381

 

 

$

2,178

 

 

$

2,682

 

 

$

2,178

 

Sales by Products

(In thousands)

 

 

Three months ended

 

Twelve months ended

 

December 31,

 

September 30,

 

December 31,

 

December 31,

 

2021

 

2021

 

2020

 

2021

 

2020

Commercial products

$

1,169

 

$

1,522

 

$

1,154

 

$

4,682

 

$

5,404

Military maritime products

 

1,236

 

 

1,227

 

 

2,592

 

 

5,183

 

 

11,424

Total net sales

$

2,405

 

$

2,749

 

$

3,746

 

$

9,865

 

$

16,828

Non-GAAP Measures

In addition to the results in this release that are presented in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”), we provide certain non-GAAP measures, which present operating results on an adjusted basis. These non-GAAP measures are supplemental measures of performance that are not required by or presented in accordance with U.S. GAAP and, include:

  • total availability, which we define as our ability on the period end date to access additional cash if necessary under our short-term credit facilities, plus the amount of cash on hand on that same date;
  • adjusted EBITDA, which we define as net income (loss) before giving effect to restructuring expenses, financing charges, income taxes, non-cash depreciation, stock compensation, incentive compensation, and change in fair value of warrant liability; and
  • adjusted gross margins, which we define as our gross profit margins during the period without the impact from excess and obsolete, in-transit and net realizable value inventory reserve movements that do not reflect current period inventory decisions.

We believe that our use of these non-GAAP financial measures permits investors to assess the operating performance of our business relative to our performance based on U.S. GAAP results and relative to other companies within the industry by isolating the effects of items that may vary from period to period without correlation to core operating performance or that vary widely among similar companies, and to assess liquidity, cash flow performance of the operations, and the product margins of our business relative to our U.S. GAAP results and relative to other companies in the industry by isolating the effects of certain items that do not have a current period impact. However, our presentation of these non-GAAP measures should not be construed as an indication that our future results will be unaffected by unusual or infrequent items or that the items for which we have made adjustments are unusual or infrequent or will not recur. Further, there are limitations on the use of these non-GAAP measures to compare our results to other companies within the industry because they are not necessarily standardized or comparable to similarly titled measures used by other companies. We believe that the disclosure of these non-GAAP measures is useful to investors as they form part of the basis for how our management team and Board of Directors evaluate our operating performance.

Total availability, adjusted EBITDA and adjusted gross margins do not represent cash generated from operating activities in accordance with U.S. GAAP, are not necessarily indicative of cash available to fund cash needs and are not intended to and should not be considered as alternatives to cash flow, net income and gross profit margins, respectively, computed in accordance with U.S. GAAP as measures of liquidity or operating performance. Reconciliations of these non-GAAP measures to the most directly comparable financial measures calculated and presented in accordance with U.S. GAAP are provided below.

 

As of

(in thousands)

December 31,

 

September 30,

 

December 31,

2021

 

2021

 

2020

Total borrowing capacity under credit facility

$

4,042

 

 

$

4,552

 

 

$

4,121

 

Less: Line of credit borrowings, gross(1)

 

(2,279

)

 

 

(2,802

)

 

 

(2,459

)

Excess availability under credit facility(2)

 

1,763

 

 

 

1,750

 

 

 

1,662

 

Cash

 

2,682

 

 

 

381

 

 

 

1,836

 

Total availability(3)

$

4,445

 

 

$

2,131

 

 

$

3,498

 

(1)Forms 10-Q and 10-K Balance Sheets reflect the Line of credit net of debt financing costs of $109, $130, and $161, respectively.

(2)Excess availability under credit facilities - represents difference between maximum borrowing capacity of credit facility and actual borrowings

(3)Total availability- represents Company’s ‘access’ to cash if needed at point in time

 

Three months ended

 

Twelve months ended

(in thousands)

December 31,

 

September 30,

 

December 31,

 

December 31,

 

2021

 

2021

 

2020

 

2021

 

2020

Net (loss) income

$

(2,631

)

 

$

(1,140

)

 

$

65

 

 

$

(7,886

)

 

$

(5,981

)

Restructuring (recovery) expense

 

 

 

 

1

 

 

 

(16

)

 

 

(21

)

 

 

(60

)

Net (loss) income, excluding restructuring

 

(2,631

)

 

 

(1,139

)

 

 

49

 

 

 

(7,907

)

 

 

(6,041

)

Interest

 

272

 

 

 

177

 

 

 

137

 

 

 

792

 

 

 

481

 

Gain on forgiveness of PPP loan

 

 

 

 

 

 

 

 

 

 

(801

)

 

 

 

Loss on extinguishment of debt

 

 

 

 

 

 

 

117

 

 

 

 

 

 

276

 

Other income - employee retention tax credit

 

(14

)

 

 

(862

)

 

 

 

 

 

(876

)

 

 

 

Income tax benefit

 

(1

)

 

 

 

 

 

(3

)

 

 

(1

)

 

 

(5

)

Depreciation

 

45

 

 

 

43

 

 

 

44

 

 

 

188

 

 

 

184

 

Stock-based compensation

 

42

 

 

 

39

 

 

 

35

 

 

 

429

 

 

 

131

 

Other incentive compensation

 

68

 

 

 

47

 

 

 

17

 

 

 

245

 

 

 

342

 

Change in fair value of warrant liability

 

 

 

 

 

 

 

(1,188

)

 

 

 

 

 

1,086

 

Adjusted EBITDA

$

(2,219

)

 

$

(1,695

)

 

$

(792

)

 

$

(7,931

)

 

$

(3,546

)

 

Three months ended

 

Twelve months ended

(in thousands)

December 31,

 

September 30,

 

December 31,

 

December 31,

 

December 31,

2021

2021

2020

2021

2020

 

($)

 

(%)

 

($)

 

(%)

 

($)

 

(%)

 

($)

 

(%)

 

($)

 

(%)

Net sales

$

2,405

 

 

 

$

2,749

 

 

 

 

$

3,746

 

 

 

 

$

9,865

 

 

 

$

16,828

 

 

 

Reported gross profit

 

189

 

7.9

%

 

 

563

 

 

20.5

%

 

 

1,434

 

 

38.3

%

 

 

1,698

 

17.2

%

 

 

5,185

 

 

30.8

%

E&O, in-transit and net realizable value inventory reserve changes

 

165

 

6.9

%

 

 

(70

)

 

(2.5

)%

 

 

(395

)

 

(10.5

)%

 

 

156

 

1.6

%

 

 

(624

)

 

(3.7

)%

Adjusted gross margin

$

354

 

14.7

%

 

$

493

 

 

17.9

%

 

$

1,039

 

 

27.7

%

 

$

1,854

 

18.8

%

 

$

4,561

 

 

27.1

%

 

Contacts

Investor Contact:

Brett Maas

(646) 536-7331

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.